| Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability J Gorman, CSF Cheung, Z Duan, L Ou, M Wang, X Chen, C Cheng, A Biju, ... Nature Communications 15 (1), 285, 2024 | 1 | 2024 |
| Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates M Prabhakaran, F Matassoli, D Leggat, A Hoover, A Srikanth, W Wu, ... Science Translational Medicine 16 (728), eadd5960, 2024 | 5 | 2024 |
| High frequency of HIV precursor-target-specific B cells in sub-Saharan populations F Matassoli, A Cagigi, CH Shen, AR Henry, TS Johnston, CA Schramm, ... Cell Reports 42 (12), 2023 | | 2023 |
| Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates CA Schramm, D Moon, L Peyton, NS Lima, C Wake, KL Boswell, ... Nature Communications 14 (1), 7961, 2023 | 5 | 2023 |
| Vaccine elicitation and structural basis for antibody protection against alphaviruses MS Sutton, S Pletnev, V Callahan, S Ko, Y Tsybovsky, T Bylund, ... Cell 186 (12), 2672-2689. e25, 2023 | 1 | 2023 |
| Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones NS Lima, M Musayev, TS Johnston, DA Wagner, AR Henry, L Wang, ... Nature Communications 13 (1), 7733, 2022 | 8* | 2022 |
| Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4 HC Welles, HAD King, L Nettey, N Cavett, J Gorman, T Zhou, Y Tsybovsky, ... PLoS Pathogens 18 (6), e1010574, 2022 | 7 | 2022 |
| Adaptive Immune Receptor Repertoire (AIRR) Community Guide to TR and IGImmunoglobulin (IG)T cell receptor (TR)Gene annotation Gene Annotation L Babrak, S Marquez, CE Busse, WD Lees, E Miho, M Ohlin, ... Immunogenetics: Methods and Protocols, 279-296, 2022 | | 2022 |
| Adaptive Immune Receptor Repertoire (AIRR) Community Guide to Repertoire Analysis S Marquez, L Babrak, V Greiff, KB Hoehn, WD Lees, ET Luning Prak, ... Immunogenetics: Methods and Protocols, 297-316, 2022 | 6 | 2022 |
| Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates KS Corbett, M Gagne, DA Wagner, S O’Connell, SR Narpala, DR Flebbe, ... Science 374 (6573), 1343-1353, 2021 | 94 | 2021 |
| Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants L Wang, T Zhou, Y Zhang, ES Yang, CA Schramm, W Shi, A Pegu, ... Science 373 (6556), eabh1766, 2021 | 219* | 2021 |
| Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses M Mukhamedova, D Wrapp, CH Shen, MSA Gilman, TJ Ruckwardt, ... Immunity 54 (4), 769-780. e6, 2021 | 40 | 2021 |
| Isolation of new CAP256-VRC26 lineage members reveals determinants of breadth and potency N Doria-Rose, L Damron, J Gorman, C Schramm, YT Lai, R Rawi, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 24, 2021 | | 2021 |
| Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth RS Roark, H Li, WB Williams, H Chug, RD Mason, J Gorman, S Wang, ... Science 371 (6525), 2021 | 52 | 2021 |
| Convergent evolution in breadth of two VH6-1-encoded influenza antibody clonotypes from a single donor NC Wu, SF Andrews, JE Raab, S O’Connell, CA Schramm, X Ding, ... Cell host & microbe 28 (3), 434-444. e4, 2020 | 17 | 2020 |
| Broadly Neutralizing Monoclonal Antibodies Against HIV-1 V1V2 Env Region CA Schramm, J Gorman, J Mascola, LS Shapiro, L Morris, NA Doria-Rose, ... US Patent App. 16/718,322, 2020 | | 2020 |
| The ADC API: a web API for the programmatic query of the AIRR Data Commons S Christley, A Aguiar, G Blanck, F Breden, SAC Bukhari, CE Busse, ... Frontiers in big Data 3, 22, 2020 | 32 | 2020 |
| HIV-1 envelope and MPER antibody structures in lipid assemblies K Rantalainen, ZT Berndsen, A Antanasijevic, T Schiffner, X Zhang, ... Cell Reports 31 (4), 2020 | 65 | 2020 |
| Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region CA Schramm, J Gorman, J Mascola, LS Shapiro, L Morris, NA Doria-Rose, ... US Patent 10,519,222, 2019 | 2 | 2019 |
| Isolation and structure of an antibody that fully neutralizes isolate SIVmac239 reveals functional similarity of SIV and HIV glycan shields J Gorman, RD Mason, L Nettey, N Cavett, GY Chuang, D Peng, ... Immunity 51 (4), 724-734. e4, 2019 | 14 | 2019 |
John mascolaNational Institutes of Health在 mail.nih.gov 的电子邮件经过验证
